Lataa...
Circulating Soluble Receptor for Advanced Glycation End Product Identifies Patients With Bicuspid Aortic Valve and Associated Aortopathies
OBJECTIVE—: A total of 30% to 50% of patients with bicuspid aortic valve (BAV) require surgery for aortic valve replacement (AVR), ascending aortic replacement (AA), or both. To prevent adverse aortic events, they are risk stratified using imperfect criteria based on imaging modalities. As a result,...
Tallennettuna:
| Julkaisussa: | Arterioscler Thromb Vasc Biol |
|---|---|
| Päätekijät: | , , , , , , , , , |
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
2014
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6685423/ https://ncbi.nlm.nih.gov/pubmed/25231638 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1161/ATVBAHA.114.303784 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|